|
AGS
|
0.4 μmol/L
|
CCK-8 assay, four-parameter logistic regression model
|
Download PDF
|
|
HGC27
|
0.6 μmol/L
|
CCK-8 assay, four-parameter logistic regression model
|
Download PDF
|
|
PANC-1
|
4.8 µM
|
MTT assay
|
Download PDF
|
|
SNU308
|
12.01 nM
|
alamarBlue assay
|
Download PDF
|
|
TGBC24
|
31.8 nM
|
alamarBlue assay
|
Download PDF
|
|
GEM-S AsPC-1
|
0.066 µM
|
WST-1 assay
|
Download PDF
|
|
GEM-R AsPC-1
|
179 µM
|
WST-1 assay
|
Download PDF
|
|
GEM-S MIA PaCa-2
|
0.64 µM
|
WST-1 assay
|
Download PDF
|
|
GEM-R MIA PaCa-2
|
61.6 µM
|
WST-1 assay
|
Download PDF
|
|
GEM-S PANC-1
|
0.047 µM
|
WST-1 assay
|
Download PDF
|
|
GEM-R PANC-1
|
67.6 µM
|
WST-1 assay
|
Download PDF
|
|
GEM-S SW1990
|
0.081 µM
|
WST-1 assay
|
Download PDF
|
|
GEM-R SW1990
|
95.6 µM
|
WST-1 assay
|
Download PDF
|
|
Hup-T3
|
>250 µM
|
MTT assay
|
Download PDF
|
|
Panc 03.27
|
>250 µM
|
MTT assay
|
Download PDF
|
|
Panc 08.13
|
>250 µM
|
MTT assay
|
Download PDF
|
|
LoVo
|
>250 µM
|
MTT assay
|
Download PDF
|
|
HT-29
|
>250 µM
|
MTT assay
|
Download PDF
|
|
LS174T
|
>250 µM
|
MTT assay
|
Download PDF
|
|
SW403
|
25 ±5 µM
|
MTT assay
|
Download PDF
|
|
FHC
|
>250 µM
|
MTT assay
|
Download PDF
|
|
CCD-112CoN
|
>250 µM
|
MTT assay
|
Download PDF
|
|
MRC-5
|
>250 µM
|
MTT assay
|
Download PDF
|
|
GBC-SD
|
1.23 µM
|
CCK8 assay
|
PMC13050350
|
|
GBC-SD
|
0.34 µM
|
CCK8 assay
|
PMC13050350
|
|
NOZ
|
1.87 µM
|
CCK8 assay
|
PMC13050350
|
|
NOZ
|
5.62 µM
|
CCK8 assay
|
PMC13050350
|
|
RBE
|
< 1 μM
|
MTS assay
|
PMC12930748
|
|
HuccT1
|
< 1 μM
|
MTS assay
|
PMC12930748
|
|
SNU1079
|
< 1 μM
|
MTS assay
|
PMC12930748
|
|
SSP-25
|
35 nM
|
CCK-8 assay, nonlinear regression (log[inhibitor] vs. normalized response, variable slope model) in GraphPad Prism 9.0.
|
PMC13109053
|
|
SSP25-GR
|
4070 nM
|
CCK-8 assay, nonlinear regression (log[inhibitor] vs. normalized response, variable slope model) in GraphPad Prism 9.0.
|
PMC13109053
|
|
KKU213
|
2053 nM
|
CCK-8 assay, nonlinear regression (log[inhibitor] vs. normalized response, variable slope model) in GraphPad Prism 9.0.
|
PMC13109053
|
|
KKU213-GR
|
15470 nM
|
CCK-8 assay, nonlinear regression (log[inhibitor] vs. normalized response, variable slope model) in GraphPad Prism 9.0.
|
PMC13109053
|
|
HMEC-1s
|
4.546 nM
|
resazurin reduction assay
|
Download PDF
|
|
ECC-1 cells
|
1.29 µM (24h), 1.04 µM (48h)
|
MTT assay, nonlinear regression (log(inhibitor) vs. response, variable slope) in GraphPad Prism.
|
Download PDF
|
|
NOZ
|
0.07 µM
|
viability assays
|
Download PDF
|
|
GBC-SD
|
0.12 µM
|
viability assays
|
Download PDF
|
|
NOZ-R
|
1.79 µM
|
viability assays
|
Download PDF
|
|
GBC-SD-R
|
2.28 µM
|
viability assays
|
Download PDF
|
|
JXQ-3D-1404R1
|
194.50 μM
|
CellTiter-Glo® Luminescent Cell Viability Assay, calculated by four-parameter curve analysis
|
PMC12554496
|
|
JXQ-3D-1404R2
|
2.67 μM
|
CellTiter-Glo® Luminescent Cell Viability Assay, calculated by four-parameter curve analysis
|
PMC12554496
|
|
PANC-1
|
11.88 µM
|
CCK-8 assay
|
Download PDF
|
|
PANC-1
|
23.38 µM
|
CCK-8 assay
|
Download PDF
|
|
MiaPaCa-2
|
23.20 µM
|
CCK-8 assay
|
Download PDF
|
|
MiaPaCa-2
|
71.32 µM
|
CCK-8 assay
|
Download PDF
|
|
CFPAC-1
|
27.47 µM
|
CCK-8 assay
|
Download PDF
|
|
CFPAC-1
|
16.44 µM
|
CCK-8 assay
|
Download PDF
|
|
BxPC-3
|
3.089 µM
|
CCK-8 assay
|
Download PDF
|
|
BxPC-3
|
1.819 µM
|
CCK-8 assay
|
Download PDF
|
|
A549
|
35.71 μmol/L
|
Cell viability assay (CCK-8 kit)
|
PMC12907970
|
|
A549/GR
|
499.43 μmol/L
|
Cell viability assay (CCK-8 kit)
|
PMC12907970
|
|
A549
|
1.17 μmol/L
|
Cell viability analysis (CCK-8 kit)
|
PMC12907970
|
|
P1-KRAS PDCO
|
0.003 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P2-KRAS PDCO
|
0.003 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P2-SMAD4 PDCO
|
0.003 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P4-KRAS PDCO
|
0.003 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P5-KRAS PDCO
|
0.001 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P6-KRAS PDCO
|
0.003 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P7-KRAS PDCO
|
0.001 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P7-SMAD4 PDCO
|
0.001 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P8-KRAS PDCO
|
0.001 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
P9-KRAS PDCO
|
0.003 µM
|
RealTime-Glo™ MT Cell Viability Assay; calculated using GraphPad Prism version 8.4.3.
|
Download PDF
|
|
EGI-1 WT
|
7.5 µM
|
MTT test
|
Download PDF
|
|
EGI-1 CR
|
12.0 µM
|
MTT test
|
Download PDF
|
|
EGI-1 FR
|
14.6 µM
|
MTT test
|
Download PDF
|
|
PANC-1
|
48.79 mM
|
MTT assay
|
Download PDF
|
|
ASPC-1
|
8.69 mM
|
MTT assay
|
Download PDF
|
|
PANC-1
|
0.32 ± 0.09 µM
|
Crystal violet staining, absorbance measurement at 595 nm, calculated using GraphPad Prism 6 software.
|
Download PDF
|
|
PANC-1
|
0.09 ± 0.02 µM
|
Crystal violet staining, absorbance measurement at 595 nm, calculated using GraphPad Prism 6 software.
|
Download PDF
|
|
HPAF-II
|
6922 ± 2265 µM
|
Crystal violet staining, absorbance measurement at 595 nm, calculated using GraphPad Prism 6 software.
|
Download PDF
|
|
HPAF-II
|
2138 ± 337.3 µM
|
Crystal violet staining, absorbance measurement at 595 nm, calculated using GraphPad Prism 6 software.
|
Download PDF
|
|
ISHIKAWA cells
|
2.82 µM
|
MTT colorimetric assay, IC50 estimated by nonlinear regression using a four-parameter logistic model
|
Download PDF
|
|
ISHIKAWA cells
|
1.42 µM
|
MTT colorimetric assay, IC50 estimated by nonlinear regression using a four-parameter logistic model
|
Download PDF
|
|
SW1573
|
0.004 ± 0.0006 µM
|
Prestoblue™Cell Viability reagent, sigmoidal dose-response (variable slope) curve fitted using a four-parameter logistic regression model (log (inhibitor) vs. normalized response Variable slope (four parameters))
|
Download PDF
|
|
H23
|
0.0033 ± 0.00025 µM
|
Prestoblue™Cell Viability reagent, sigmoidal dose-response (variable slope) curve fitted using a four-parameter logistic regression model (log (inhibitor) vs. normalized response Variable slope (four parameters))
|
Download PDF
|
|
HUCCT1
|
2.3 μM
|
CCK-8 assay following 48 h treatment with a range of gemcitabine concentrations
|
Download PDF
|
|
RBE
|
3.8 μM
|
CCK-8 assay following 48 h treatment with a range of gemcitabine concentrations
|
Download PDF
|
|
KPC-Luc
|
66.79 μM
|
Cell viability assay
|
Download PDF
|
|
GR-KPC
|
3.50 μM
|
Cell viability assay
|
Download PDF
|
|
AsPC-1 (Gem-S)
|
0.045 µM
|
WST-1 assay
|
Download PDF
|
|
AsPC-1 (Gem-R)
|
229.5 µM
|
WST-1 assay
|
Download PDF
|
|
PANC-1 (Gem-S)
|
0.061 µM
|
WST-1 assay
|
Download PDF
|
|
PANC-1 (Gem-R)
|
59.62 µM
|
WST-1 assay
|
Download PDF
|
|
TCC-SUP
|
10.4 (3.4-20.6) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
TCC-SUP CDDP
|
3.2 (1.5-4.9) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
TCC-SUP VBL
|
6.6 (5.8-7.5) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
TCC-SUP Gem
|
133.2 (73.2-205.1) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
TCC-SUP CDDP/Gem
|
95.1 (80.4-111.5) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
RT-112
|
11.9 (7.7-17.4) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
RT-112 CDDP
|
11.6 (3.1-19.4) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
RT-112 VBL
|
7.1 (3.9-11.1) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
RT-112 Gem
|
325.0 (254.5-413.5) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
RT-112 CDDP/Gem
|
70.9 (44.8-103.5) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
UMUC-3
|
16.0 (15.3-16.7) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
UMUC-3 CDDP
|
150.5 (123.8-181.7) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
UMUC-3 VBL
|
232.0 (211.2-255.2) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
UMUC-3 Gem
|
900.7 (753.6-1,066.0) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
UMUC-3 CDDP/Gem
|
224.0 (199.7-250.0) nM
|
Sulforhodamine B (SRB) assay; IC50 (95%CI) were determined using GraphPad Prism 7.03 by fitting a four-parameter variable slope equation ([inhibitor] vs. response).
|
Download PDF
|
|
PANC-1
|
43.53 µg/ml
|
MTT assay
|
PMC12290208
|
|
PANC1
|
~1.5 µM
|
CCK-8 assay
|
Download PDF
|
|
PANC1
|
~0.5 µM
|
CCK-8 assay
|
Download PDF
|
|
PANC1
|
~2.5 µM
|
CCK-8 assay
|
Download PDF
|
|
BXPC3
|
~1.5 µM
|
CCK-8 assay
|
Download PDF
|
|
BXPC3
|
~0.5 µM
|
CCK-8 assay
|
Download PDF
|
|
BXPC3
|
~2.5 µM
|
CCK-8 assay
|
Download PDF
|
|
MIA-PaCa-2
|
0.70 ± 0.09 µM
|
SRB assay
|
Download PDF
|
|
GEM-resistant MIA-PaCa-2
|
9.82 ± 0.03 µM
|
SRB assay
|
Download PDF
|
|
BxPc3 cell line
|
0.7 µM
|
AlamarBlue assay kit, GraphPad® Prism® software
|
Download PDF
|
|
BxPC-3
|
1.98 mM
|
CCK-8 assay, dose-response data fitted to a sigmoidal curve using GraphPad Prism 8.0
|
Download PDF
|
|
PANC-1
|
1.96 mM
|
CCK-8 assay, dose-response data fitted to a sigmoidal curve using GraphPad Prism 8.0
|
Download PDF
|
|
BxPC-3/GR
|
52.02 mM
|
CCK-8 assay, dose-response data fitted to a sigmoidal curve using GraphPad Prism 8.0
|
Download PDF
|
|
PANC-1/GR
|
83.50 mM
|
CCK-8 assay, dose-response data fitted to a sigmoidal curve using GraphPad Prism 8.0
|
Download PDF
|
|
PANC-1/GR (control)
|
85.80 mM
|
CCK-8 assay (implied)
|
Download PDF
|
|
PANC-1/GR (siPLA2G16-1 knockdown)
|
28.52 mM
|
CCK-8 assay (implied)
|
Download PDF
|
|
PANC-1/GR (siPLA2G16-2 knockdown)
|
6.817 mM
|
CCK-8 assay (implied)
|
Download PDF
|
|
RBE cells
|
5 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12220003
|
|
OCI-LY19
|
2.4 nM
|
Cell viability assay
|
Download PDF
|
|
OCI-LY3
|
14.4 nM
|
Cell viability assay
|
Download PDF
|
|
SUDHL4
|
0.002721 µM
|
Cell viability assay
|
Download PDF
|
|
SUIT-2
|
5.53 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
PANC-1
|
5.28 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
TKCC-2.1 Lo
|
5.39 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
AsPC-1
|
5.54 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
HPAF-II
|
6.37 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
HPAC
|
6.41 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
SU 86.86
|
8.41 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
TB32047
|
10.70 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
TB32047 OxR
|
5.58 nM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC11965318
|
|
PANC-1
|
10 μM
|
Cell Proliferation Kit II (XTT) assay, calculated using GraphPad Prism 9 software.
|
PMC12086086
|
|
RRM1-T734A PANC-1
|
0.1 μM
|
Cell Proliferation Kit II (XTT) assay, calculated using GraphPad Prism 9 software.
|
PMC12086086
|
|
J82
|
0.55 μM
|
CCK-8 assay
|
PMC11830209
|
|
UMUC3
|
1.11 μM
|
CCK-8 assay
|
PMC11830209
|
|
T24
|
1.21 μM
|
CCK-8 assay
|
PMC11830209
|
|
PATU8988T
|
1 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12119658
|
|
AsPC-1
|
1 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12119658
|
|
A549
|
0.80 µM
|
MTT assay
|
Download PDF
|
|
shRNA-FGA cells
|
1.65 µM
|
MTT assay
|
Download PDF
|
|
A549
|
3.344 µM
|
CCK-8 Assay Kit, absorbance at 490 nm
|
PMC11866803
|
|
A549-GR
|
58.63 µM
|
CCK-8 Assay Kit, absorbance at 490 nm
|
PMC11866803
|
|
T24 cells
|
0.77 μM
|
MTT assay (inferred)
|
Download PDF
|
|
UM-UC-3 cells
|
0.32 μM
|
MTT assay (inferred)
|
Download PDF
|
|
T24-R cells
|
12.06 μM
|
MTT assay (inferred)
|
Download PDF
|
|
UM-UC-3-R cells
|
9.51 μM
|
MTT assay (inferred)
|
Download PDF
|
|
A549 cells
|
180 nM
|
MTT assay
|
Download PDF
|
|
Panc-1
|
3.82 ± 1.04 μM
|
MTT assay
|
PMC11438785
|
|
MiaPaca-2
|
2.13 ± 0.22 μM
|
MTT assay
|
PMC11438785
|
|
A549
|
0.029 ±0.002 μM
|
CCK8 assay
|
PMC11600051
|
|
H460
|
0.025 ±0.036 μM
|
CCK8 assay
|
PMC11600051
|
|
HCC827
|
0.049 ±0.052 μM
|
CCK8 assay
|
PMC11600051
|
|
H1975
|
0.273 ±0.199 μM
|
CCK8 assay
|
PMC11600051
|
|
AsPC-1
|
>100 μM
|
MTT assay, nonlinear regression analysis by GraphPad Prism 5.0 software
|
PMC11646436
|
|
PANC-1
|
>100 μM
|
MTT assay, nonlinear regression analysis by GraphPad Prism 5.0 software
|
PMC11646436
|
|
BxPC-3
|
4.35 μM
|
MTT assay, nonlinear regression analysis by GraphPad Prism 5.0 software
|
PMC11646436
|
|
Mia PaCa-2
|
>100 μM
|
MTT assay, nonlinear regression analysis by GraphPad Prism 5.0 software
|
PMC11646436
|
|
SU.86.86
|
>100 μM
|
MTT assay, nonlinear regression analysis by GraphPad Prism 5.0 software
|
PMC11646436
|
|
HT1080 cells
|
12.8 nM
|
WST-8 reagent to determine cell viability, absorption measured at 450 nM, IC50 determined with ImageJ version 1.53k.
|
PMC11696348
|
|
GR-HT1080 cells
|
30.8 nM
|
WST-8 reagent to determine cell viability, absorption measured at 450 nM, IC50 determined with ImageJ version 1.53k.
|
PMC11696348
|
|
Hs27 cells
|
4.48 nM
|
WST-8 reagent to determine cell viability, absorption measured at 450 nM, IC50 determined with ImageJ version 1.53k.
|
PMC11696348
|
|
VX2 cells
|
13.24 µM
|
CCK-8 assay
|
Download PDF
|
|
VX2 cells
|
1.37 µM
|
CCK-8 assay
|
Download PDF
|
|
AsPC-1 cells
|
1.6 µM
|
MTT assay, Compusyn software
|
Download PDF
|
|
PANC-1
|
~1000 nM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
MIA PaCa-2
|
~100 nM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
RBT-7
|
12.2 nM
|
MTT assay
|
PMC11622161
|
|
RBT-7-ML
|
13.2 nM
|
MTT assay
|
PMC11622161
|
|
RBT-7-TP
|
11.8 nM
|
MTT assay
|
PMC11622161
|
|
UM-UC3
|
10.57 nM
|
MTS assay
|
PMC11542063
|
|
UM-UC3
|
40.57 nM
|
Luminescence assay (CellTiter-Glo® 3D Cell Viability Assay)
|
PMC11542063
|
|
DPC-X3 cells
|
> 600 µmol/L
|
CCK-8 assay
|
Download PDF
|
|
Panc-1 cells
|
2 μM
|
trypan exclusion viability assay measured with the Vi-CELL™ XR Cell Viability Analyzer
|
PMC11590551
|
|
GBC-X1 cells
|
0.0035 µmol/L
|
CCK-8 assay
|
PMC11399391
|
|
BxPC-3
|
680.35 nM
|
CCK-8 assay
|
Download PDF
|
|
MIA-PaCa-2
|
728.81 nM
|
CCK-8 assay
|
Download PDF
|
|
Gem-R BxPC-3
|
>1200 nM
|
CCK-8 assay
|
Download PDF
|
|
Gem-R MIA-PaCa-2
|
>1200 nM
|
CCK-8 assay
|
Download PDF
|
|
PANC-1
|
7.63 μM
|
MTT viability assay
|
Download PDF
|
|
Miapaca-2
|
0.23 ± 0.02 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12225906
|
|
Miapaca-2-GR
|
28.34 ± 2.15 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12225906
|
|
Capan-2
|
0.45 ± 0.03 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12225906
|
|
Capan-2-GR
|
10.23 ± 0.87 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12225906
|
|
Oncopig BCCL
|
1.647 µM
|
MTT assay; GraphPad software
|
Download PDF
|
|
Oncopig BCCL
|
0.3308 µM
|
MTT assay; GraphPad software
|
Download PDF
|
|
T24
|
1.242 µM
|
MTT assay; GraphPad software
|
Download PDF
|
|
T24
|
0.1787 µM
|
MTT assay; GraphPad software
|
Download PDF
|
|
5637
|
0.9881 µM
|
MTT assay; GraphPad software
|
Download PDF
|
|
5637
|
0.1208 µM
|
MTT assay; GraphPad software
|
Download PDF
|
|
NOZ
|
0.011 μM
|
Cell Counting Kit-8 (CCK-8) assay, dose-response curves
|
PMC10923318
|
|
NOZ GemR
|
4.464 μM
|
Cell Counting Kit-8 (CCK-8) assay, dose-response curves
|
PMC10923318
|
|
T24
|
10.15 μM
|
IC50 analysis
|
Download PDF
|
|
5637
|
10.52 μM
|
IC50 analysis
|
Download PDF
|
|
h-Panc03.27
|
0.012 ± 0.2 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
h-Panc03.27
|
0.008 ± 0.5 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
h-Panc1
|
0.53 ± 0.7 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
h-Panc1
|
0.13 ± 0.7 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
m-3275
|
0.06 ± 0.3 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
m-3275
|
0.04 ± 0.5 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
h-HPAF-II
|
0.25 ± 0.4 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
h-HPAF-II
|
0.09 ± 0.4 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
h-CFPAC-I
|
0.013 ± 0.3 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
h-CFPAC-I
|
0.009 ± 0.6 µM
|
Cell-Titer Glo assay
|
Download PDF
|
|
ADCA117
|
0.0013 mM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
Download PDF
|
|
SNU1196/GR
|
2.291 µM
|
MTT assay
|
Download PDF
|
|
SNU1196
|
0.038 µM
|
MTT assay
|
Download PDF
|
|
ICC-X2 cells
|
> 60 µmol/L
|
CCK-8 assay
|
PMC10807924
|
|
EGI-1
|
20 nM
|
Sulforhodamine B (SRB) assay, 5-parameter logistic regression
|
Download PDF
|
|
TFK-1
|
13 nM
|
Sulforhodamine B (SRB) assay, 5-parameter logistic regression
|
Download PDF
|
|
SK-ChA-1
|
23 nM
|
Sulforhodamine B (SRB) assay, 5-parameter logistic regression
|
Download PDF
|
|
CBC2T-2 cells
|
0.009 μM
|
CCK-8 reagent assay
|
PMC10701331
|
|
Patu-T
|
2–16 nM
|
SRB assay, interpolation in Graphpad-Prism
|
Download PDF
|
|
Suit-2.007
|
2–16 nM
|
SRB assay, interpolation in Graphpad-Prism
|
Download PDF
|
|
Suit-2.028
|
2–16 nM
|
SRB assay, interpolation in Graphpad-Prism
|
Download PDF
|
|
Patu-T GR
|
0.7–12 μM
|
SRB assay, interpolation in Graphpad-Prism
|
Download PDF
|
|
Suit-2.007 GR
|
0.7–12 μM
|
SRB assay, interpolation in Graphpad-Prism
|
Download PDF
|
|
Suit-2.028 GR
|
0.7–12 μM
|
SRB assay, interpolation in Graphpad-Prism
|
Download PDF
|
